++
Chapter 33. Rheumatoid Arthritis Medication Therapy Management Data Set
++
++
++
Diagnosis of rheumatoid arthritis is most commonly seen in which decade of life?
++
++
++
++
++
++
++
++
++
++
++
++
Which of the following is the most specific serological marker used to help confirm the diagnosis and predict the severity of rheumatoid arthritis?
++
++
++
a. Positive rheumatoid factor
++
++
b. Elevated erythrocyte sedimentation rate
++
++
c. Elevated C-reactive protein
++
++
d. Anti-cyclic citrullinated peptide antibodies
++
++
++
Which of the following is a therapeutic goal specifically associated with the treatment of rheumatoid arthritis, in comparison to osteoarthritis?
++
++
++
a. Prevention of disease progression
++
++
++
++
c. Preservation of joint function
++
++
d. Improvement of overall quality of life
++
++
++
Using living room language, which of the following terms is best described by the phrase, "a time in which the symptoms of rheumatoid arthritis might be higher than normal"?
++
++
++
++
++
++
++
++
++
++
++
++
Which of the following is an important component of a medication action plan (MAP)?
++
++
++
a. Address only the most important action steps for the patient
++
++
b. Use technical language to ensure the reviewing physician is comfortable with this plan
++
++
c. Create a MAP for every disease state the patient has during this visit to ensure completeness
++
++
d. Combine 2 medication-related problems to decrease the list
++
++
++
Which of the following scenarios associated with rheumatoid arthritis requires a referral to a physician?
++
++
++
a. A patient currently taking methotrexate reports mild joint swelling and moderate fatigue
++
++
b. A patient currently taking etanercept reports a runny nose but denies a fever
++
++
c. A patient currently taking methotrexate reports she was exposed to someone who currently has shingles
++
++